Resección de páncreas e hígado en pacientes testigos de Jehová

1.    Chua R., Tham K.F.:  Will “no blood” kill Jehovah Witnesses?.  Singapore Med J 47. 994-1001.2006;quiz 2 
2.    Acts ch.15 v. 29.   The New English Bible with the Apocrypha,  Oxford University PressOxford1970: 
3.    Dixon J.L., Smalley M.G.:  Jehovah's Witnesses. The surgical/ethical challenge.  JAMA 246. 2471-2472.1981; 
4.    Cunningham J.D., Fong Y., Shriver C., et al:  One hundred consecutive hepatic resections. Blood loss, transfusion, and operative technique.  Arch Surg 129. 1050-1056.1994; 
5.    Jarnagin W.R., Gonen M., Fong Y., et al:  Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade.  Ann Surg 236. 397-406.2002;discussion 407 
6.    Fernandez-Del Castillo C., Morales-Oyarvide V., McGrath D., et al:  Evolution of the Whipple procedure at the Massachusetts General Hospital.  Surgery 152. (Suppl 1): S56-S63.2012; 
7.    Drackley A., Newbold K.B., Paez A., Heddle N.:  Forecasting Ontario's blood supply and demand.  Transfusion 52. 366-374.2012; 
8.    Emmert M.Y., Salzberg S.P., Theusinger O.M., et al:  How good patient blood management leads to excellent outcomes in Jehovah's witness patients undergoing cardiac surgery.  Interactive Cardiovasc Thorac Surg 12. 183-188.2011;
9.    Barakat O., Cooper , Jr. , Jr.J.R., Riggs S.A., et al:  Complex liver resection for a large intrahepatic cholangiocarcinoma in a Jehovah's witness: a strategy to avoid transfusion.  J Surg Oncol 96. 249-253.2007;
10.    Shiozawa S., Haga S., Kumazawa K., et al:  Pylorus-preserving pancreaticoduodenectomy without homologous blood transfusion in a Jehovah's witness with pancreatic cancer: report of a case.  Hepatogastroenterology 50. 272-274.2003; 
11.    Jabbour N., Gagandeep S., Mateo R., et al:  Transfusion free surgery: single institution experience of 27 consecutive liver transplants in Jehovah's Witnesses.  J Am Coll Surg 201. 412-417.2005;
12.    Jabbour N., Gagandeep S., Bramstedt K.A., et al:  To do or not to do living donor hepatectomy in Jehovah's Witnesses: single institution experience of the first 13 resections.  Am J Transplant 5. 1141-1145.2005; 
13.    Jarnagin W.R., Gonen M., Maithel S.K., et al:  A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection.  Ann Surg 248. 360-369.2008; 
14.    Fischer M., Matsuo K., Gonen M., et al:  Relationship between intraoperative fluid administration and perioperative outcome after pancreaticoduodenectomy: results of a prospective randomized trial of acute normovolemic hemodilution compared with standard intraoperative management.  Ann Surg 252. 952-958.2010; 
15.    Carless P.A., Henry D.A., Moxey A.J., et al:  Cell salvage for minimising perioperative allogeneic blood transfusion.  Cochrane Database Syst Rev . (4): CD001888.2010;
16.    Marsh J.C., Bevan D.H.:  Haematological care of the Jehovah's Witness.  Br J Haematol 119. 25-37.2002; 
17.    Tonia T., Mettler A., Robert N., et al:  Erythropoietin or darbepoetin for patients with cancer.  Cochrane Database Syst Rev 12. CD003407.2012; 
18.    Melendez J.A., Arslan V., Fischer M.E., et al:  Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction.  J Am Coll Surg 187. 620-625.1998;
19.    Jayaraman S., Gonen M., Brennan M.F., et al:  Laparoscopic distal pancreatectomy: evolution of a technique at a single institution.  J Am Coll Surg 211. 503-509.2010;
20.    Martin , 2nd , 2ndR.C., Brennan M.F., Jaques D.P.:  Quality of complication reporting in the surgical literature.  Ann Surg 235. 803-813.2002; 
21.    Man K., Fan S.T., Ng I.O., et al:  Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study.  Ann Surg 226. 704-711.1997;discussion 711–713 
22.    Bui L.L., Smith A.J., Bercovici M., et al:  Minimising blood loss and transfusion requirements in hepatic resection.  HPB (Oxford) 4. 5-10.2002;
23.    Lentschener C., Gomola A., Grabar S., et al:  The effect of erythropoietin on allogeneic blood requirement in patients undergoing elective liver resection: a model simulation.  Anesthes Analg 98. 921-926.2004;
24.    Wu C.C., Ho W.M., Cheng S.B., et al:  Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a “blood transfusion”-free hepatectomy.  Ann Surg 243. 173-180.2006; 
25.    Gorlinger K., Dirkmann D., Hanke A.A., et al:  First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study.  Anesthesiology 115. 1179-1191.2011; 
26.    Huang Z.Q., Xu L.N., Yang T., et al:  Hepatic resection: an analysis of the impact of operative and perioperative factors on morbidity and mortality rates in 2008 consecutive hepatectomy cases.  Chin Med J 122. 2268-2277.2009; 
27.    Cescon M., Vetrone G., Grazi G.L., et al:  Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years.  Ann Surg 249. 995-1002.2009; 
28.    Poon R.T., Fan S.T., Lo C.M., et al:  Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database.  Ann Surg 240. 698-708.2004;discussion 710 
29.    Ahmad S.A., Edwards M.J., Sutton J.M., et al:  Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients.  Ann Surg 256. 529-537.2012; 
30.    Waters J.H., Yazer M., Chen Y.F., Kloke J.:  Blood salvage and cancer surgery: a meta-analysis of available studies.  Transfusion 52. 2167-2173.2012; 
31.    Correa-Gallego C., Brennan M.F., D'Angelica M., et al:  Operative drainage following pancreatic resection: analysis of 1122 patients resected over 5 years at a single institution.  Ann Surg . 2013 Jan 28;[Epub ahead of print]
32.    Goodnough L.T., Shander A., Brecher M.E.:  Transfusion medicine: looking to the future.  Lancet 361. 161-169.2003; 
33.    Vamvakas E.C., Blajchman M.A.:  Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention.  Blood 113. 3406-3417.2009; 
34.    Isbister J.P., Shander A., Spahn D.R., et al:  Adverse blood transfusion outcomes: establishing causation.  Transfus Med Rev 25. 89-101.2011; 
35.    Acheson A.G., Brookes M.J., Spahn D.R.:  Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis.  Ann Surg 256. 235-244.2012